Evidence map›Paper›PMID 42696385›Full record

ReviewPediatric dermatology2026

Wound Microbes in Epidermolysis Bullosa: A Focus on Topical Strategies for Management of Pseudomonas Aeruginosa Colonization.

Carly Mulinda, Laura E Levin, Margaret E Scollan, Kimberly D Morel

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pediatric dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Carly MulindaVagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Laura E LevinDepartment of Dermatology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Margaret E ScollanDepartment of Dermatology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.ORCID https://orcid.org/0000-0002-6706-9446
Kimberly D MorelDepartment of Dermatology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epidermolysis bullosa (EB) is a chronic blistering skin disease with a propensity for bacterial colonization, critical colonization and/or infection, namely with Staphylococcus aureus and Pseudomonas aeruginosa. While P. aeruginosa cutaneous and systemic infection are associated with significant morbidity in the EB population, critical colonization poses its own risks, given its impairment of wound healing and the hypothesized association of flagellated bacteria with wound-induced skin cancer. There is a paucity of published literature describing topical management of P. aeruginosa colonization/critical colonization in patients with EB. The purpose of this review is to describe current and emerging treatment modalities for the topical management of P. aeruginosa colonization/critical colonization in patients with EB, extrapolating from current evidence-based practices in other skin conditions that may be relevant to patients with EB.

Indexed as

Anti-Bacterial AgentsEpidermolysis BullosaPseudomonas aeruginosaPseudomonas InfectionsWound InfectionAdministration, TopicalAnti-Infective Agents, LocalHumansAnti-Bacterial AgentsAnti-Infective Agents, Localantisepticepidermolysis bullosapediatric dermatologypseudomonas aeruginosatopical antimicrobials

Identifiers

PMID42696385
PMCPMC13544516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.